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Abstract
CD4
+ and CD8
+ T cells, the main effectors of adaptive cellular immune responses, differentiate from immature, non-
functional CD4
+CD8
+ double-positive T (DPT) cells in the thymus. Increased proportions of circulating DPT lymphocytes
have been observed during acute viral infections; in chronic viral diseases, the role and repartition of extra-thymic DPT cells
remain largely uncharacterized. We performed a phenotypic analysis of DPT cells in blood and liver from patients chronically
infected by hepatitis C (HCV) or B (HBV) viruses. The highest percentages of DPT cells, predominantly CD4
highCD8
low, were
observed in patients infected by HCV, while HBV-infected patients mostly displayed CD4
lowCD8
high and CD4
highCD8
high DPT
cells. All proportions of DPT cells were higher in liver than in blood with, for each subpopulation referred to above, a
correlation between their frequencies in these two compartments. In HCV patients, intra-hepatic DPT cells displayed more
heterogeneous activation, differentiation and memory phenotypes than in the blood; most of them expressed CD1a, a
marker of T cell development in the thymus. Ex vivo, the inoculation of liver slices with HCV produced in cell culture was
accompanied by a disappearance of CD8
high cells, suggesting a direct effect of the virus on the phenotype of DPT cells in
the liver. Our results suggest that, in half of the patients, chronic HCV infection promotes the production of DPT cells,
perhaps by their re-induction in the thymus and selection in the liver.
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Introduction
CD4
+ and CD8
+ T cells are the main effectors of the adaptive
cellular immune responses, and are required to clear viral infections
[1]. These cells derive from precursors migrating from the bone
marrow to the thymus, where they express rearranged T cell
receptors (TCR) and CD3 together with both CD4 and CD8 co-
receptors, from whichCD4
+ or CD8
+ single positive naı ¨ve T cellsare
selected [2]. A small proportion of circulating CD4
+CD8
+ double-
positive T (DPT) cells has been described in humans [3], as well as in
animal models [4–7]. A few of them are immature T cells escaping
from the thymus [8]. Others may be terminally differentiated cells re-
expressing the second TCR co-receptor before their death [2]. More
often, DPT cells are functional effector/memory T cells specific for
antigens from a variety of viral pathogens [9,10]. Their proportion
can increase from about 1% up to 20% of circulating lymphocytes
during infections by human immunodeficiency virus (HIV) or
Epstein-Barr virus [11,12]. Extra-thymic DPT lymphocytes are
probably not restricted to viral infections, since they have also been
f o u n da s s o c i a t e dw i t hm a l i g n a n tt u m o r s[ 1 3 , 1 4 ]o ri nt a r g e to r g a n so f
autoimmune conditions [2,15]. The roles played by extra-thymic
DPT cells are still largely unknown, and their repartition only
partially characterized.
DPT cells have been observed at low frequencies in the blood of
patients chronically infected by HCV [9]. This virus establishes a
persistent infection in the liver of about 75% of the patients; it is
still not understood why the immune system fails to clear HCV in
most instances. During the acute phase of the experimental
infection of a chimpanzee with HCV (the only animal model that
develops chronic infection, as in humans), the frequencies of both
circulating and intra-hepatic DPT cells increased [9]. Correlation
of the proportions of these cells with serum viral loads suggested a
link between DPT cells and control of HCV infection. However,
this result was obtained in an animal that spontaneously resolved
its HCV infection, and has not been compared to those of animals
becoming chronically infected. In addition, no data is available
regarding DPT cells in the liver of HCV-infected patients. In this
study, we sought to concomitantly determine the patterns of DPT
cells in peripheral blood and liver of chronically HCV-infected
patients. We compared these patterns with those of patients
presenting with chronic infections of the liver by HBV.
Materials and Methods
Patients and human tissues, sample preparation
Twenty-seven chronically HCV mono-infected (57610 year
old), eight HBV mono-infected patients (4069), six HCV-HIV co-
infected (50613), three non-infected patients and two healthy
individuals were included in this study. All subjects were followed
in the Liver Unit of Cochin Hospital (AP-HP, Paris, France);
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20145Institutional review board of Cochin Hospital approved the study
protocol.
Paired blood samples and liver biopsies were obtained from all
patients who had an indication for a liver biopsy to follow up or
stage their liver condition; large piece of the biopsies were fixed
and examined by the Pathology Unit of Cochin Hospital; stage of
fibrosis was determined with certainty in twenty HCV mono-
infected (5 F1, 8 F2, 5 F3 and 2 F4) and seven HBV mono-
infected (2 F0, 3 F1, 2 F2 and 1 F3) patients. Part of the fresh
liver biopsies (.1-cm long, 1-mm diameter) were mechanically
disrupted on a 100 mm-pore mesh in 3 ml of non-supplemented
RPMI culture medium; freshly isolated liver infiltrating lympho-
cytes (LILs) were centrifuged, resuspended in phosphate buffer
saline (PBS), pH=7.4, containing 2% fetal calf serum (FCS), and
immediately stained for phenotyping analysis. Peripheral blood
mononuclear cells (PBMCs) were isolated from blood by
centrifugation over a Ficoll gradient, washed twice and re-
suspended in PBS supplemented with 2% FCS. For one non-
infected and one HCV-infected patients liver biopsies were snap
frozen for in situ analysis.
Flow cytometry
Freshly isolated paired PBMCs and LILs were incubated with
4 ml of the BD Multitest 6-Color TBNK Reagent (BD Biosciences)
for 30 minutes at 4uC in the dark. The cells were washed,
incubated with paraformaldehyde 2% in PBS, harvested on a
FACSCanto or a LSRII (Becton Dickinson) and analyzed with
Diva or FlowJo softwares. Cell death evaluated with the Live/
Dead Fixable Blue Dead-Cell-Stain Kit (Molecular Probes,
Invitrogen) as indicated by the manufacturer, was always lower
than 5% of DPT cells. In average, the total number of events
acquired was 10
6; a result below 100 DPT cells was considered as
not meaningful and plotted as zero percent.
In situ immunofluorescence
Snap-frozen liver biopsies were cut in 10-mm serial sections
using a cryotome (Leica CM), fixed in acetone, incubated with
PBS/5% BSA/5% AB serum for 30 min, then with primary
antibodies (CD4 (Novacastra), CD8, CD3 (Abcam); 1/100
dilution each) for 1h30. After two washes in PBS containing
0.5% Tween 20, sections were incubated with 1/200 diluted
Alexa-Fluor-488- and -546-coupled secondary antibodies for an
hour, washed, fixed in paraformaldehyde 2% in PBS, counter-
stained with Hoechst (1 mg/ml) and incubated with MEM
Essential Amino Acids for 20 minutes. Slides were mounted with
Fluoromount-G (Southern Biotech). Sections were analyzed with
an Axiovert-100M Zeiss microscope equipped with an Orca ER
camera (220uC, pixels 1344/1024, Hamamatsu). Photographs
were colorized with Image J 1.38. The fluorescence intensities of
the red and green channels were obtained with the Plot Profile
function of the software.
Human liver slices
Macroscopically non-tumoral/non-pathological liver tissue was
collected from a HCV-, HIV- and HBV-negative patient
undergoing surgery for liver tumor resection. Serial 350 mm-thick
slices were obtained by cutting the liver sample in ice cold PBS
using a Vibratome (Leica, Heidelberg, Germany) and placed onto
Millipore filters in Dulbecco’s modified Eagle’s medium with
glutamine containing 10% fetal calf serum, MEM non essential
amino acids, 25 mM HEPES and penicillin-streptomycin (Life
Technologies, MD), then incubated at 37uCi na nH 2O-saturated
atmosphere comprised of 95% air-5% CO2.
Production of HCV particles in cell culture
HCVcc (JFH-1 strain of genotype 2a) was produced in HuH-7.5
cells, as previously described [16]. Briefly, culture supernatants
were harvested, clarified by low-speed centrifugation to remove
cell debris, filtered through 0.45 mm PVDF membranes, concen-
trated using Vivaspin filters (MWCO=1,000,000 daltons), and
kept frozen at 280uC until used.
Statistical analyses
Pearson’s correlation between the proportions of DPT cell
subpopulations in blood and liver for each patient was tested using
a t-test; the ratios of CD4
highCD8
low over CD4
lowCD8
high DPT
cells were compared using a Mann-Whitney (non-parametric) test.
Ethics Statement
The patients’ informed consent was obtained in writing prior to
collecting samples during routine medical visits, and in compliance
with the standard Ethical Guidelines of the Institutional Review
Board of Cochin Hospital (Paris) who approved the study.
Results
HCV-infected patients have often a high proportion of
DPT cells in both blood and liver
To analyze DPT cells, freshly isolated PBMCs and LILs were
stained with fluorochrome-coupled antibodies recognizing im-
mune cell surface markers. Within the CD45
+ cell population, and
after exclusion of CD16
+ CD56
+ NK (or NKT) cells and CD19
+ B
cells, the CD3
+ T cells were analyzed for CD4 and CD8
expressions (Figure 1A). The bottom right panel of Figure 1A
further depicts how we determined the proportion of total DPT
cells —regions of interest (ROIs) 1, 2 and 3 in the upper right
quadrant— in blood and liver from chronically HCV-infected
patients; the results are shown in Figure 1B. The average
proportion of these cells in the liver was more than 2-fold (mean
6 SD=10.167.5%; median=8.2%) that in the blood (4.665%;
3.1%), which suggests that DPT cells are sequestered in the liver or
locally induced. However, since the liver of uninfected patients
also contained a higher proportion of DPT cells (Figure 1B), the
difference of their proportions between these two compartments
was not linked to HCV infection.
We found higher proportions of circulating DPT cells than in a
previous study [9], which could relate to their more stringent
phenotyping (cf. Materials and Methods) or other methodological
factors, such as ethnicity (not accounted for in France) and way of
life (obesity, alcohol consumption, etc…), or viral genotype: the
present group included mixed HCV genotypes (with a majority of
1b), whereas the previous only included genotype 1 (mostly 1a) [9].
Another factor could be the stage of clinical progression. In five
patients presenting with acute HCV infections (,4 months), we
observed proportions of circulating DPT cells ranging between
0.05 and 1.3%, similarly to uninfected patients. However, this
result might not reflect intra-hepatic DPT cells, if not re-
circulating. In addition, proportions of circulating DPT cells were
not determined during the very first weeks of HCV primo-
infection; as spontaneous clearance of HCV infection occurs much
more frequently in the chimpanzee than in acute patients, we do
not know what the outcome of the five patients in our study would
have been in the absence of treatment. It nevertheless indicates
that proportions of circulating DPT cells vary with the step of
HCV infection. Thus, although the stages of chronic HCV
infections (early vs. late) at which patients were included have not
been determined, they could explain differences between these two
studies.
CD4
+CD8
+ T Cells in Chronic Hepatitis B and C
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e20145HCV-infected patients have a higher proportion of DPT
cells than HBV-infected patients
In all groups, frequencies of DPT cells in the liver were higher
than in the blood. The numbers of patients were too small in some
groups to meaningfully perform multiple comparisons; their values
are only provided as an indication. In the blood, the proportion of
DPT cells in HBV mono-infected patients (1.961.6%; 1.4%) were
not very different from those in non-infected patients (1.260.6%;
1.2%) and healthy controls (2.260.6%; 2.2%), but lower than in
HCV-infected patients (4.665%; 3.1%), or HCV-HIV co-infected
(4.563.8%; 1.9%). In the liver, the proportions of DPT cells in
HBV mono-infected (6.763.8%; 5.6%) and non-infected
(6.961.5%; 6.3%) patients were also lower than in HCV-mono-
infected (10.167.5%; 8.2%) or HCV-HIV co-infected
(12.366.1%; 11.9%) patients. The percentages of DPT cells in
the two groups of HCV and HBV mono-infected patients were
Figure 1. Proportions of DPT cells in the blood and liver of chronically HCV- or HBV-infected, HCV-HIV co-infected and non-
infected patients. A, Representative dot plot of PBMCs labeled with the BD Multitest 6-Color TBNK Reagent: CD45
+CD16
2CD56
2 CD19
2CD3
+
PBMCs were analyzed for CD4 and CD8 expressions; viability of the CD4
+CD8
+ cells was separately assessed with Live/Dead Cell Viability Assay
(.95%). B, Proportions of total CD4
+CD8
+CD3
+ (DPT) cells in peripheral blood and liver biopsy for each patient of the different groups. In grey, the
experimental points with values above the thresholds (dashed lines) determined in (C), with the corresponding numbers of patients at the top (above
threshold/total). C, Determination of the thresholds: 3% in the blood and 10% in the liver.
doi:10.1371/journal.pone.0020145.g001
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difference reached statistical significance in the blood (p,0.05),
but not in the liver (p.0.15).
In all groups, the proportions of DPT cells were spread along a
broad range of values with a bottleneck in the number of patients
(Figure 1C). In the blood, it was observed for around 3% DPT
cells. Albeit less obvious in the liver, based on the difference of
proportions of DPT cells between blood and liver (cf. above), a
three-time higher threshold was determined. Strikingly, almost all
patients with proportions of DPT cells above the thresholds were
HCV mono-infected (blood: 14/27; liver: 13/27) or HCV-HIV
co-infected (blood: 2/6; liver: 3/6), except for two who were
mono-infected by HBV (2/8 for both blood and liver) and had
values close to the thresholds (Figure 1B). This suggested that
about half of chronically HCV-infected patients had a higher
proportion of DPT cells, both in blood and in liver, the bottleneck
reflecting perhaps the existence of two types of patients, which
could underlie a lack of power to reach statistical significance in
the liver.
Predominant CD4
highCD8
low DPT cell subpopulation in
chronically HCV-infected patients
In fact, three main phenotypes of DPT cells can be
distinguished with flow cytometry analyses: CD4
highCD8
low,
CD4
lowCD8
high and a less numerous subpopulation of
CD4
highCD8
high DPT cells: in Figure 1A (lower right panel) these
populations respectively correspond to ROIs 1, 3 and 2 (upper
right quadrant). The former are generally CD8alpha-alpha, and
may correspond to terminally differentiated cells [2]; in fact, some
of them are NKT cells [17], but those cells were excluded from
our analysis (cf. above). CD4
lowCD8
high DPT cells are CD8alpha-
beta [2], which has raised the hypothesis that those in the
peripheral blood might be terminally differentiated cells generated
during viral infections [9]. However, this idea has been questioned,
in particular by the recent report that the proportion of circulating
CD4
highCD8
low T cells increased during HIV infections [18].
Therefore, CD4
highCD8
low DPT cells, also observed within
tumors [19], might instead be generated during chronic immune
processes. We therefore reanalyzed the proportions of total DPT
cells according to these three subpopulations, looking for the
presence of pattern specificities, or lack thereof, in the blood and
the liver of patients chronically infected by HCV or HBV.
In the blood (Figure 2A), HCV mono-infected patients had a
higher percentage (mean 6 SD=3.564.7%; median=1.9%) of
CD4
highCD8
low cells (on the left of the graph) than HBV mono-
infected (0.760.8%; 0.4%) patients, while the proportion of
CD4
lowCD8
high cells was of the same order of magnitude in both
groups: HBV (1.060.8%; 0.9%) vs. HCV (0.760.9%; 0.4%)
mono-infected patients. In the liver (Figure 2B), the proportions of
CD4
highCD8
low cells were increased in HCV (4.865%; 2%)
compared to HBV (1.061.1%; 0.7%) mono-infected patients,
while these HBV (4.163.5%; 3.3%) and HCV (3.263.2%; 2.4%)
patients had a similar proportion of CD4
lowCD8
high cells. As with
total DPT cells, the proportions were spread within a broad range
of values in all groups (Figures 2A and 2B), some of which with
very few patients.
We next looked for correlations between the different
subpopulations of DPT cells in the blood and liver for each
patient, and tested the statistical significance of the difference
between HCV and HBV mono-infected patients. The propor-
tions of CD4
highCD8
low DPT cells in blood and liver of HCV
mono-infected patients significantly correlated (p,0.01; exclud-
ing extreme values increased the significance; Figure 3A), while it
was those of CD4
lowCD8
high (Figure 3B) and CD4
highCD8
high
(not shown) DPT cells that correlated in HBV mono-infected
patients (p,0.001, for both); for the other subpopulations of DPT
cells, the values in the blood and liver did not significantly
correlate in either group. This led us to determine for each
patient the ratio of the proportions of CD4
highCD8
low over
CD4
lowCD8
high DPT cells in the blood and the liver. In average
this ratio was at least five times higher in the blood (p,0.01) and
the liver (p,0.02) of HCV mono-infected patients compared to
the other groups (Figure 4).
The presence of DPT cells was verified in situ in snap frozen
liver biopsies. CD4 (green) and CD8 (red) cell markers were
studied side-by-side in one HCV-infected (Figure 5, right panels)
and one non-infected (Figure 5, left panels) patient. Cells with
either signal, or both, were detected; their relative quantifications
in individual cells (insets; semi log scale) suggested that more DPT
cells displayed a greater red (CD8) than green (CD4) signal in
non-infected than in HCV-infected liver (Figure 5, middle and
lower left panels; yellowish cells). In contrast, DPT cells with
equivalent green and red signals were found at a higher
frequency in HCV-infected than in non-infected liver. The
distinct nature of the signals measured by fluorescence micros-
copy (staining density in whole cells) and by flow cytometry
(integration of staining at the cell surface) precludes the direct
comparison of signal intensities between liver sections and
extracted LILs, respectively. Nevertheless, the in situ results
indirectly confirm the existence of distinct patterns of DPT cells
in HCV-infected and uninfected patients.
Intra-hepatic DPT cells in chronically HCV-infected
patients are effector/memory T cells and express CD1a
To determine the degree of differentiation and activation of
DPT cells, we performed additional phenotypic analyses in six
patients for whom enough cells had been harvested. In the blood
of chronically HCV-infected patients, while CD1a, CD25, CD27,
CD28 or CD62L markers were not detected in most DPT cells,
about 30% of them expressed the activation marker CD38. The
proportions of CCR7
+ cells were similar to those in HCV-
uninfected individuals; more than half of the CD4
lowCD8
high DPT
cells expressed CCR7, a marker of naı ¨ve and memory T cells,
which was detected much less often in CD4
highCD8
low DPT cells.
Contrasting with these results, DPT cell subpopulations were more
heterogeneous in the liver; 53% of CD4
lowCD8
high, 59% of
CD4
highCD8
low and 75% of CD4
highCD8
high DPT cells of
chronically HCV-infected patients expressed CD45RO, CD62L
and CCR7, typical of central memory phenotype, while 23 to 46%
of them were minus either for CCR7 or CD62L, i.e. corresponded
to effector memory T cells. Most intra-hepatic CD4
lowCD8
high
and CD4
highCD8
low DPT cells expressed the marker CD25, and
had lost the expression of CD27 or CD28, or both, suggesting they
were differentiated cells. CD4
highCD8
high DPT cells were more
heterogeneous since about half of them retained CD27 and CD28
expressions. Strikingly, 80 to 90% of intra-hepatic DPT cells
expressed CD1a, a marker of T cell development within the
thymus [20], at odd with its lack of detection in circulating DPT
cells.
Experimental evidence for the direct regulation of DPT
cell phenotype by HCV in human liver
We have obtained evidence that naı ¨ve human liver slices can be
infected ex vivo by infectious HCV particles (HCVcc) produced in
permissive hepatic cell lines [21]. We reasoned that if chronic
inflammation was underlying the DPT cell phenotype observed in
HCV-infected patients, no major change should occur after only a
CD4
+CD8
+ T Cells in Chronic Hepatitis B and C
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inoculated them with HCVcc [16]; after five days, LILs were
extracted from the slices and harvested by flow cytometry using the
same procedure as for liver biopsies (cf. Materials and Methods).
Surprisingly, upon infection the LILs were more numerous than in
control slices (Figure 6), although this could result from either cell
proliferation or increased cell survival. Interestingly, we found that
HCVcc induced T cell proliferation (measured by staining with
CFDA-SE [22]) in liver slices, but not in immune cells previously
extracted from liver (not shown), in line with the former hypothesis.
Moreover, the proportions of CD8
+ single-positive T cells decreased
as well as both CD4 and CD8 expression levels, suggesting a direct
effect of the presence of the virus on the differentiation of intra-
hepatic lymphocytes. Finally, the proportion of DPT cells was
slightly higher, and CD4
highCD8
low cells were more frequently
observed, whereas CD4
lowCD8
high and CD4
highCD8
high cells
almost disappeared.
Discussion
The goal of our study was to gain some insight regarding the
origin of extra-thymic DPT cells during HCV infections. Intra-
hepatic and circulating DPT cells were comprised of populations
of activated, central and effector memory cells, with heterogeneous
differentiation patterns, in accordance with results in the liver of a
chimpanzee at the acute phase of HCV infection [9]. Discrepan-
cies in the proportions of circulating DPT cells could relate to
methodological differences and/or patient samples (e.g. stages of
HCV infection). With comparable criteria, the chronically HCV-
infected patients of the present study had heterogeneous
proportions of DPT cells, and displayed a different pattern than
chronically HBV-infected patients.
Chronic inflammation of the liver is unlikely the sole reason
underlying enhanced proportions of DPT cells, since the latter
were detected in only half of the patients chronically infected by
Figure 2. Proportions of CD4
highCD8
low, CD4
highCD8
high and CD4
lowCD8
high DPT cells in the blood and liver of patients. A,
Proportions of each DPT cell subpopulations: CD4
hiCD8
lo (1), CD4
hiCD8
hi (2) and CD4
loCD8
hi (3) in the blood of each patient (1 dot=1 patient);
percentages lower than 0.05 were plotted as 0. B, Same procedure as in (A) with LILs. Horizontal lines represent the values of the median for each
DPT subpopulation in each group of patients; the three subpopulations of DPT cells correspond to the quadrants set-up in the lower right panel of
Figure 1A, (numbers between brackets).
doi:10.1371/journal.pone.0020145.g002
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HBV infections did not yield the same patterns of DPT cells,
suggesting the existence of viral specificities. Although the
proportion CD4
highCD8
low cells is increased in HIV-infected
patients [18], it was not obvious in our patients that HCV co-
Figure 3. HCV and HBV mono-infected patients display distinct
patterns of DPT cells. A, Correlation between the proportions of
CD4
hiCD8
lo DPT cell subpopulations (1) in blood and liver of HCV mono-
infected patients; other subpopulations did not significantly correlate.
B, Correlation between the proportions of CD4
loCD8
hi DPT cell
subpopulations (3) in blood and liver of HBV mono-infected patients;
CD4
hiCD8
hi correlated to the same extent as CD4
loCD8
hi (respectively 2
and 3) in HBV-infected patients (not shown). Each dot represents the
proportions in blood and liver for a patient; significance of Pearson’s
correlation was tested using a t-test. The numbers between brackets
correspond to the quadrants set-up in Figure 1A, lower right panel.
doi:10.1371/journal.pone.0020145.g003
Figure 4. Average ratios of CD4
highCD8
low cells/CD4
lowCD8
high
cells in the blood and liver of each group of patients. Error bars
represent standard deviations. Statistical analysis was performed using
a Mann-Whitney test.
doi:10.1371/journal.pone.0020145.g004
Figure 5. In situ study of LILs by immuno-fluorescence in liver
sections of uninfected and HCV-infected patients. Results
obtained with liver biopsies from an uninfected (left panels) and an
HCV-infected (right panels) patient. 10-mm serial sections were labeled
with CD4 and CD8 antibodies (middle and bottom panels) or isotype
controls (top panels). Scale bar: 100 mm. Right Insets: relative
fluorescence intensities along the red bars in the left insets plotted
on a semi-logarithmic scale (0–100), for the red (CD8) and green (CD4)
light channels.
doi:10.1371/journal.pone.0020145.g005
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HIV-HCV co-infected patients displayed proportions of
CD4
lowCD8
high cells as high as in HBV mono-infected patients.
Therefore, the mechanisms of induction of CD4
highCD8
low cells
by HCV and HIV are likely distinct, pointing again at virus
specificities.
Experimentally, HCV infection changed the phenotype of intra-
hepatic DPT cells, ex vivo. Thus, the presence of HCVcc modified
the patterns of T and DPT cells in liver slices. Such effect was not
observed with extracted hepatic immune cells and, therefore, likely
resulted from hepatocyte infection after inoculation of the slices
with HCVcc. The change having taken place within five days, the
peculiar pattern of DPT cells observed in patients hence cannot
only be explained by chronic infection. Alternately, albeit not
exclusively, the pattern of intra-hepatic DPT cells could result
from direct effects of HCV on other local/resident immune cells
[23], or have more indirect causes.
LILs of patients chronically infected with HCV include a
population of DPT cells expressing CD1a
+ cells. However, unlike
naı ¨ve DPT cells that escape from the thymus [8,24], circulating
DPT cells in HCV patients had an activated, differentiated
memory phenotype. In addition, they did not express CD1a; even
if recruited to the liver, these cells were unlikely to re-express this
marker, since in the periphery it is generally expressed onto lipid
antigen-presenting cells [25]. Chronic immune processes generally
deplete the thymus [26,27]; for DPT cells to originate from the
thymus, at least in some patients, HCV infection had to overcome
the depletion by re-inducing T cell production.
Thus, the presence in the liver of CD1a
+ cells expressing both
CD4 and CD8 co-receptors could result from the accelerated
recruitment of precursors from the bone marrow followed by their
rapid development towards a T cell phenotype in the thymus. It
could be a compensatory mechanism for the loss of terminally
differentiated T lymphocytes resulting from the chronic infection
or, more directly, viral factors. Indeed, the existence of a plasticity
of the thymus has recently been recognized [27,28] and, here,
could involve the enhanced production of IL-7 in the liver [28,29].
According to this hypothesis, HCV infection would induce the
rapid differentiation and/or relocation of CD1a
+ DPT cells in the
liver. Consistent with a correlation between predominant intra-
hepatic and circulating subpopulations, as well as progression of
their phenotype between the liver and the blood compartments,
DPT cells would be re-circulating from the liver after their local
activation, like other T cells [30].
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